PD-1, an immune checkpoint protein encoded by the PDCD1 gene, plays a crucial role in inhibiting T-cell activity, making it a key target in cancer immunotherapy. Similarly, CTLA-4, a T cell surface receptor, negatively regulates immune responses. Antibody drugs are designed to enhance anti-tumor immune responses by targeting these pathways.
At Alpha Lifetech, we specialize in providing high-quality bispecific antibody products and comprehensive bispecific antibody development services. Trust us to accelerate your research.